Kangmei Pharma | 600518 - Profitto Lordo Sulle Vendite

Prezzo Delle Azioni
1.74
Cambio Giornaliero
0.03 1.75%
Mensile
-1.14%
Annuale
-11.22%
Q2 Previsione
1.69




Profitto Lordo Sulle Vendite Cambiamento Data
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Avita Medical AUD 14.31M 639K 2025-12
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Dianthus Therapeutics USD 284K 112K 2025-12
Genomma Lab Internacional MXN 2.66B 208.35M 2026-03
Hypermarcas BRL 1.38B 16.08M 2025-12
Ionis Pharmaceuticals USD 195M 40M 2025-12
IQVIA Holdings USD 1.12B 32M 2025-12
Jiangsu Hengrui CNY 7.27B 918.27M 2025-12
Kangmei Pharma CNY 270.29M 20.26M 2025-09
Moderna USD 226M 583M 2025-12
Organon & Co USD 854M 3M 2025-12
Revvity USD 421.66M 47.06M 2025-12
Sh Fosun Pharma CNY 4.8B 93.72M 2025-09
Tectonic Therapeutic USD 0 0 2025-03
Viatris USD 1.15B 223.6M 2025-12
Wuxi Apptec CNY 6.34B 212.54M 2025-12
Xeris Pharmaceuticals USD 72.15M 8.77M 2025-12
Zz Pientze Pharmaceu CNY 296.13M 1.1B 2025-06